The US Food and Drug Administration (FDA) has initiated a permanent injunction lawsuit against Vape Junkie Ejuice for unauthorized production and distribution of e-cigarette products. The lawsuit, filed through the US Department of Justice, seeks to halt the company’s illicit sale of unauthorized e-cigarette products.
This action marks the FDA’s seventh enforcement procedure aimed at enforcing pre-market review requirements for novel tobacco products under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Despite prior warnings and the threat of further actions, Vape Junkie Ejuice continued to produce, sell, and distribute unauthorized e-cigarette products. The FDA is committed to enforcing the law and working with federal partners, including the Department of Justice, to prevent the distribution of illegal products.
The FDA has taken action against numerous manufacturers, distributors, importers, and retailers of illegal e-cigarette products in the past year. This includes issuing warning letters and filing civil penalty complaints against violators.
The Department of Justice (DOJ) has filed a lawsuit on behalf of the FDA, demanding that Vape Junkie Ejuice cease the production, sale, and distribution of their e-cigarette liquid, and obtain market authorization from the FDA before selling such products.
The initiative underscores the FDA’s commitment to regulating the e-cigarette industry and ensuring that products comply with legal requirements.
The FDA’s actions demonstrate a strong stance against the unauthorized production and distribution of e-cigarette products, aimed at protecting public health and preventing illegal marketing practices within the industry.